Nicholas Investment Partners, LP Sarepta Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $111,034 - $167,713	1,185 Added 35.6%	4,514 $584,000
Q4 2023 Feb 07, 2024	SELL	$67.31 - $124.76 $12.4 Million - $23.1 Million	-184,756 Reduced 98.23%	3,329 $321,000
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $19.3 Million - $23.2 Million	188,085 New	188,085 $22.8 Million
Q1 2023 May 11, 2023	BUY	$117.53 - $155.99 $11.4 Million - $15.1 Million	97,091 Added 107.41%	187,481 $25.8 Million
Q4 2022 Feb 10, 2023	BUY	$100.86 - $132.13 $9.12 Million - $11.9 Million	90,390 New	90,390 $11.7 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $5.71 Million - $13.3 Million	-78,970 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $572,302 - $814,696	4,558 Added 6.13%	78,970 $13.5 Million
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $7.86 Million - $10.7 Million	61,844 Added 492.08%	74,412 $10.5 Million
Q2 2020 Aug 12, 2020	SELL	$93.0 - $171.7 $2.08 Million - $3.85 Million	-22,395 Reduced 64.05%	12,568 $2.02 Million
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $62,032 - $99,124	-753 Reduced 2.11%	34,963 $3.42 Million
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $1.52 Million - $2.69 Million	-19,807 Reduced 35.67%	35,716 $4.61 Million
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $99,604 - $214,652	1,368 Added 2.53%	55,523 $4.18 Million
Q2 2019 Aug 09, 2019	SELL	$112.21 - $151.95 $183,575 - $248,590	-1,636 Reduced 2.93%	54,155 $8.23 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $1.95 Million - $2.78 Million	-18,311 Reduced 24.71%	55,791 $6.65 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $390,350 - $596,676	-4,011 Reduced 5.13%	74,102 $8.09 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $2.26 Million - $3.16 Million	19,570 Added 33.43%	78,113 $12.6 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $4.2 Million - $9 Million	58,543 New	58,543 $7.74 Million

Others Institutions Holding SRPT

# of Institutions

525

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.17 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.02 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$712 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$496 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$486 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account